BioLife Solutions Inc. BLFS
Analyst Ratings
- Consensus
- Hold — 0 Buy · 6 Hold · 0 Sell (6 analysts)
- Avg. Price Target
- $31.00 (-14.2% downside)
Key Stats
- Today's Range
- $35.92 – $36.92
- 50-Day Range
- $26.98 – $38.10
- 52-Week Range
- $17.86 – $38.10
- Volume
- 468K shs
- Average Volume
- 748K shs
- Market Cap
- $1.77 billion
- P/E Ratio
- 30.60
- Dividend Yield
- —
Valuation
- P/E Ratio
- 30.60
- Price / Book
- 4.21
- Price / Sales
- 17.18
Short Interest
- Short Interest
- 1.61%
- Days to Cover
- 10.04
Financials (TTM)
- Revenue
- $102.82 million
- Net Income
- $57.98 million
- Net Margin
- 56.39%
- Return on Equity
- 13.80%
- Debt-to-Equity
- 0.00
About BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
Related Stocks
Compare head-to-head: BLFS vs MDT·BLFS vs AXGN·BLFS vs CNMD·BLFS vs FOCL
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.